The carboxy terminus of Hsc70-interacting protein (CHIP, encoded by STUB1) functions as a dual-specificity E3 ubiquitin ligase that selectively targets pathological protein oligomers for autophagic degradation rather than proteasomal processing. CHIP's TPR domain recognizes HSP70-bound oligomeric substrates through the same conformational sensing mechanism, but the degradation pathway diverges based on the specific E2 ubiquitin-conjugating enzyme recruited. When CHIP associates with UBE2N (Ubc13
The recognition and remodeling of amyloidogenic protein species involves a sequential conformational templating mechanism mediated by HSP90-HSP70 heterocomplexes, where HSP90 serves as the primary conformational sensor while HSP70 provides the refolding machinery. This mechanism centers on HSP90's unique ability to bind partially folded client proteins through its middle domain, which recognizes the altered global fold topology that occurs when amyloidogenic segments become exposed. Upon HSP90 b
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
# Critical Evaluation of Chaperone Selectivity Hypotheses
## Hypothesis 1: Co-chaperone Heterogeneity (DNAJB6/DNAJB2)
**Weak Links:**
- The "client code" is descriptive terminology lacking mechanist...
Domain Expert
# Feasibility Assessment: Chaperone Selectivity Hypotheses
## Executive Summary
Of the five hypotheses, **Hypothesis 3 (amyloidogenic segment recognition)** emerges as most feasible for therapeutic ...
# Critical Evaluation of Chaperone Selectivity Hypotheses
## Hypothesis 1: Co-chaperone Heterogeneity (DNAJB6/DNAJB2)
**Weak Links:**
- The "client code" is descriptive terminology lacking mechanist...
Domain Expert
# Feasibility Assessment: Chaperone Selectivity Hypotheses
## Executive Summary
Of the five hypotheses, **Hypothesis 3 (amyloidogenic segment recognition)** emerges as most feasible for therapeutic ...